Description
An orally available TLR7 agonist (EC50 = 291 nM); stimulates a TLR7 immune response in two different animal models of chronic HBV infection and inhibits HIV-1 infection in human peripheral blood mononuclear cells
Formal name: 4-amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]-6(5H)-pteridinone
Synonyms: Vesatolimod
Molecular weight: 410.5
CAS: 1228585-88-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Immunology & Inflammation|Innate Immunity|Pattern Recognition||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS